Press Releases Partner Content Axtria Acquires Conexus Solutions, Uniting Agentic AI and CR... Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced the acquisition of Conexus Solutions
Sales & Marketing Sponsored Pushing through barriers to commercial launch success, with ... In this sponsored pharmaphorum podcast, Amanjeet Singh Saluja, a Principal at Axtria, discusses the current state of affairs in launch success.
Sales & Marketing Sponsored 5 forces reshaping pharma commercialisation in 2026 As infrastructure bottlenecks ease and regulatory frameworks mature, pharma's AI adoption is shifting from proof-of-concept to production-grade deployment
Digital Sponsored Axtria Ignite 2025: A VIP roundtable on agentic AI At Axtria Ignite 2025, over 20 pharma senior executives stepped into a VIP roundtable to discuss how best to unlock agentic AI’s tranformative value.
Digital Agentic AI, culture shifts, and commercialisation today: Ant... Hear Anthony Cilento, VP, data science & customer insights, at Bayer, in a post-Axtria Ignite 2025 discussion on the conference and agentic AI.
Digital Partner Content Axtria and Kedaara Capital Announce Strategic $240 Million I... The transaction delivers total liquidity of $240 million, making it one of the largest employee-centric liquidity events in the industry.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.